1. The document describes a protocol for producing recombinant adenovirus using an adenovirus expression system. Key steps include cloning the gene of interest into an adenovirus shuttle vector, co-transfecting the shuttle vector and adenovirus backbone into 293A packaging cells, identifying viral plaques, and amplifying and purifying the recombinant adenovirus.
2. Recombinant adenovirus is produced via homologous recombination between the adenovirus shuttle vector containing the gene of interest and adenovirus backbone vector in 293A cells. Small viral plaques are picked and amplified through multiple passages.
3. The purified recombinant adenovirus is obtained through PEG precipitation, CsCl gradient
Recombinant adenovirus (rAdV) is a gene transfer vector that can deliver gene sequences into cells without genome integration. rAdV has advantages such as a large transgene capacity, ability to infect dividing and non-dividing cells, and high efficiency. rAdV is commonly produced using packaging systems like AdEasy and AdMAX, which introduce the gene of interest into a shuttle vector that is recombined into a viral backbone in 293A packaging cells. Plaques are selected and amplified through multiple passages to generate high-titer virus stocks for experiments.
This document provides protocols for producing recombinant adeno-associated virus (rAAV) vectors. It first describes AAV biology, noting that AAV requires helper viruses to replicate and has nonpathogenic wildtype strains. The protocol then outlines a three-plasmid system to generate rAAV using AAV-293 packaging cells. This involves transfecting cells with vectors encoding the gene of interest flanked by AAV inverted terminal repeats along with helper plasmids. Harvested rAAV is purified using iodixanol gradient ultracentrifugation and concentrated using ultrafiltration to remove contaminants. Quality control assesses the presence of three AAV capsid proteins to confirm vector purity.
AAV production protocol:packaging,concentration and purification-gene medissuser8cc395
1. Adeno-associated virus (AAV) is a small DNA virus that does not cause disease on its own but requires assistance from other viruses like adenovirus to replicate. Recombinant AAV (rAAV) vectors are commonly used for gene delivery by replacing the viral genome with a transgene cassette.
2. Production of rAAV involves co-transfecting three plasmids (containing the transgene, Rep/Cap genes, and adenoviral genes) into AAV-293 packaging cells. Harvested viral particles are purified using iodixanol gradient ultracentrifugation.
3. Purified rAAV is concentrated and quality is assessed by detecting the
GeneMedi-AAV production protocol-packaging concentration and purificationMelissaZHANG18
1. Adeno-associated virus (AAV) is a small DNA virus that requires assistance from other viruses like adenovirus to replicate. It is commonly used as a vector for gene delivery due to its low immunogenicity.
2. Recombinant AAV (rAAV) vectors are produced using a 3-plasmid system in AAV-293 packaging cells. This results in viral particles containing the gene of interest.
3. Purification methods like iodixanol gradient ultracentrifugation are used to separate rAAV from contaminants before concentration through ultrafiltration.
GeneMedi-Lentivirus production protocol-packaging concentration and purificationMelissaZHANG18
1. The document provides guidelines for the safe use and handling of lentivirus, including conducting experiments in biosafety level 2 facilities, wearing proper protective equipment, and properly decontaminating and disposing of materials.
2. It describes how to store, dilute, and introduce lentivirus, noting that the virus can be stored at -80°C for long-term use but is sensitive to freeze-thawing.
3. The overview explains the process for producing recombinant lentivirus using a three-plasmid transfection system, including transfecting the lentiviral expression, envelope, and packaging plasmids into 293T cells to generate viral particles.
The document provides information about adenovirus (AdV) including storage, dilution, introduction, products, services, vectors, and experimental procedures for AdV production. The key steps are:
1) Transfecting virus plasmids into 293A packaging cells to produce initial virus particles.
2) Observing plaque formation and collecting isolated plaques to amplify virus through multiple passages.
3) Purifying and concentrating the amplified virus for use in transduction experiments and animal studies.
Recombinant adenovirus (rAdV) is a gene transfer vector that can deliver gene sequences into cells without genome integration. rAdV has advantages such as a large transgene capacity, ability to infect dividing and non-dividing cells, and high efficiency. rAdV is commonly produced using packaging systems like AdEasy and AdMAX, which introduce the gene of interest into a shuttle vector that is recombined into a viral backbone in 293A packaging cells. Plaques are selected and amplified through multiple passages to generate high-titer virus stocks for experiments.
This document provides protocols for producing recombinant adeno-associated virus (rAAV) vectors. It first describes AAV biology, noting that AAV requires helper viruses to replicate and has nonpathogenic wildtype strains. The protocol then outlines a three-plasmid system to generate rAAV using AAV-293 packaging cells. This involves transfecting cells with vectors encoding the gene of interest flanked by AAV inverted terminal repeats along with helper plasmids. Harvested rAAV is purified using iodixanol gradient ultracentrifugation and concentrated using ultrafiltration to remove contaminants. Quality control assesses the presence of three AAV capsid proteins to confirm vector purity.
AAV production protocol:packaging,concentration and purification-gene medissuser8cc395
1. Adeno-associated virus (AAV) is a small DNA virus that does not cause disease on its own but requires assistance from other viruses like adenovirus to replicate. Recombinant AAV (rAAV) vectors are commonly used for gene delivery by replacing the viral genome with a transgene cassette.
2. Production of rAAV involves co-transfecting three plasmids (containing the transgene, Rep/Cap genes, and adenoviral genes) into AAV-293 packaging cells. Harvested viral particles are purified using iodixanol gradient ultracentrifugation.
3. Purified rAAV is concentrated and quality is assessed by detecting the
GeneMedi-AAV production protocol-packaging concentration and purificationMelissaZHANG18
1. Adeno-associated virus (AAV) is a small DNA virus that requires assistance from other viruses like adenovirus to replicate. It is commonly used as a vector for gene delivery due to its low immunogenicity.
2. Recombinant AAV (rAAV) vectors are produced using a 3-plasmid system in AAV-293 packaging cells. This results in viral particles containing the gene of interest.
3. Purification methods like iodixanol gradient ultracentrifugation are used to separate rAAV from contaminants before concentration through ultrafiltration.
GeneMedi-Lentivirus production protocol-packaging concentration and purificationMelissaZHANG18
1. The document provides guidelines for the safe use and handling of lentivirus, including conducting experiments in biosafety level 2 facilities, wearing proper protective equipment, and properly decontaminating and disposing of materials.
2. It describes how to store, dilute, and introduce lentivirus, noting that the virus can be stored at -80°C for long-term use but is sensitive to freeze-thawing.
3. The overview explains the process for producing recombinant lentivirus using a three-plasmid transfection system, including transfecting the lentiviral expression, envelope, and packaging plasmids into 293T cells to generate viral particles.
The document provides information about adenovirus (AdV) including storage, dilution, introduction, products, services, vectors, and experimental procedures for AdV production. The key steps are:
1) Transfecting virus plasmids into 293A packaging cells to produce initial virus particles.
2) Observing plaque formation and collecting isolated plaques to amplify virus through multiple passages.
3) Purifying and concentrating the amplified virus for use in transduction experiments and animal studies.
A new system called the "admid system" has been developed for efficiently generating recombinant adenoviruses in E. coli. The system uses Tn7-mediated transposition to insert expression cassettes into an adenoviral genome plasmid (admid) maintained in E. coli. Transfer vectors containing the expression cassette flanked by Tn7 elements transpose the cassette into the E1 region of the admid. Recombinant admids produce infectious adenovirus after transfection into producer cells. The system generates pure, clonal adenovirus stocks without multiple rounds of purification. It allows rapid, high-throughput production of recombinant adenoviruses for gene therapy and other applications.
1. The document provides guidelines for safely conducting experiments with lentiviruses, which should be done in a biosafety level 2 facility and while wearing proper protective equipment.
2. Lentiviruses should be stored at -80°C for long-term storage and diluted in ice water or medium kept at 4°C.
3. Recombinant lentiviruses are produced by co-transfecting lentiviral, envelope, and packaging plasmids into 293T cells, collecting the supernatant, and purifying and titrating the virus.
Cloning vectors are small DNA molecules that are used to artificially carry foreign genetic material into host cells. They contain features like an origin of replication, antibiotic resistance genes, and restriction enzyme sites. The document discusses different types of cloning vectors used for plant gene cloning, including plasmids, Ti/Ri plasmids from Agrobacterium, and plant viruses. Agrobacterium-mediated transformation uses disarmed Ti plasmids from Agrobacterium tumefaciens and involves co-cultivation of plant explants with Agrobacterium, selection of transformed cells, and regeneration of whole plants. Binary vector systems are now commonly used, involving transfer of a binary plasmid without integration into the Ti plasmid
DNA cloning techniques allow for the reproduction of DNA fragments. There are two main approaches: cell-based cloning using living cells and in vitro cloning using PCR. The cloning process involves cutting out the gene of interest and a host plasmid with the same restriction enzyme, ligating the gene into the plasmid, transforming bacteria with the new plasmid, and selecting for transformed colonies. Common cloning vectors include plasmids, bacteriophages, cosmids, YACs, and retroviral vectors which allow incorporation of foreign DNA into host genomes. PCR cloning strategies like TA cloning take advantage of Taq polymerase adding extra adenines to PCR products, allowing ligation into vectors with thymidine overhangs.
PRODUCTION OF SEROTYPE 6-DERIVED RECOMBINANT ADENO-ASSOCIATED VIRUS IN SERUM-...Dr. Érica Schulze
This document describes research into producing recombinant adeno-associated virus (rAAV) using serum-free suspension cultures of HEK 293 cells. The researchers investigated the effects of different DNA, polyethyleneimine (PEI) transfection reagent, and cell concentrations on rAAV yields. They found that transfecting at a cell concentration of 3x10^6 cells/mL resulted in a 2.5-3.5 fold increase in infectious virus particles (IVP) and genomic particles (Vg) compared to 1x10^6 cells/mL. When testing different PEI:DNA ratios, IVP ranged from 1.19x10^8 to 1.03x10^9 IVP/
This document summarizes a single-use platform for purifying adenovirus at scale. The platform uses disposable filters, cassettes, and membrane adsorbers to purify adenovirus from cell culture harvest in one day. Key steps include clarification with a depth filter, concentration/diafiltration with ultrafiltration cassettes, primary purification on a Q membrane adsorber, polishing with an STIC membrane to remove DNA, and final concentration/buffer exchange. The platform achieved 55% overall yield while meeting targets for host cell protein, DNA, and endonuclease concentration in the final product. It provides a standardized process that can be easily scaled up and reduces development time for new viral vaccine products
A comprehensive study of shuttle vector & binary vector and its rules of in ...PRABAL SINGH
Vector: A vector is a DNA molecule that has the ability to replicate autonomously in an appropriate host cell and into which the DNA fragment to be cloned is integrated for cloning
Recombinant DNA technology involves joining DNA fragments from different sources to create a new DNA fragment. This involves selecting the target DNA, a cloning vector to carry the inserted DNA, DNA ligases to join the pieces, restriction enzymes to cut the DNA, and a host cell to replicate the new DNA. Common vectors include bacterial plasmids and phages that can carry inserted DNA fragments of varying sizes. The process involves cutting, joining, and replicating the DNA within the host cell. Applications include gene therapy, transgenic plants and animals, and industrial production of proteins and chemicals. Recent advances allow modifying proteins through site-directed mutagenesis.
This document discusses various gene transfer methods in animals, including viral and non-viral approaches. Viral methods include retroviruses, adenoviruses, adeno-associated viruses, baculoviruses, which can integrate the transferred gene into the host cell's genome. Non-viral methods discussed are transfection techniques like calcium phosphate precipitation, DEAE-dextran, lipids, microinjection, gene guns, ultrasound, and electroporation. These physical methods deposit naked DNA directly into cells without viral vectors. The document provides detailed protocols for many of these gene transfer techniques.
This document discusses different types of cloning vectors. It describes that vectors are used to carry foreign DNA into host cells. There are two main types of transformation vectors - cloning vectors which are used to increase copies of cloned DNA fragments, and expression vectors which are used to express foreign genes as proteins. Some examples of commonly used cloning vectors include pBR322 and pUC18/19, while examples of expression vectors include pET28 and pRSET vectors. The document then discusses various properties desirable in vectors such as an origin of replication, antibiotic resistance genes, and regulatory elements. It describes different types of vectors including plasmid vectors, bacteriophage vectors, cosmids, BACs/YACs, and mini chromosomes.
jove-protocol-51306-using-rna-interference-to-investigate-innate-immune-respo...Brandon S Guthrie
This document summarizes a protocol for using RNA interference (RNAi) to investigate the innate immune response in mouse macrophages. The protocol describes optimizing transfection of two mouse macrophage cell lines, RAW264.7 and J774A.1, using a 96-well nucleofection system. It then details monitoring the effects of RNAi-mediated gene knockdown on the innate immune response after stimulating the macrophages with lipopolysaccharide (LPS). As an example, it discusses using RNAi to inhibit Toll-like receptor family members, which sense LPS and regulate innate immunity.
This document summarizes a seminar presentation on the production of DNA vaccines. It begins by discussing the importance of vaccines in addressing infectious diseases and problems with traditional vaccines. It then covers topics like the advantages of DNA vaccines over recombinant protein vaccines, designing plasmid DNA constructs for vaccines, antigen expression systems, successful DNA vaccines to date, delivery methods like needle-free injection and microspheres, and the use of adjuvants to enhance vaccine activity.
The document discusses various methods of transfection in animals. Transfection is the process of introducing nucleic acids into eukaryotic cells. It describes viral transfection using bacteria like Agrobacterium tumefaciens and viruses. Non-viral methods include chemical transfection using calcium phosphate, liposomes, polyamines. Mechanical transfection employs microinjection or particle bombardment. Common chemical methods are calcium phosphate precipitation, polyplexes, and liposomes/lipoplexes. Viruses used are retroviruses, adenoviruses, adeno-associated viruses. Bacterial and viral vectors allow for integration into the host genome while chemical and mechanical are often transient.
This study evaluated the effectiveness of using a lentivirus delivery system to introduce CRISPR/Cas9 genome editing in a salmonid fish cell line. The researchers optimized transfection conditions and achieved up to 60% editing efficiency at the desired RIG-I and EGFP loci. While lentivirus integration led to high editing rates, it can also result in off-target effects. The study demonstrated the potential of CRISPR/Cas9 for modeling disease resistance in fish, though more work is still needed to minimize off-target mutations.
CLONING VECTORS FOR YEAST AND Agrobacterium tumefaciens.pptxsandhyagokulnathan
A cloning vector is a DNA molecule that is used to carry a foreign DNA into the host cell. It has the ability to self replicate and integrate into the host cell.Saccharomyces cerevisiae. Development of plasmid is most commonly found in strains of S. cerevisiae its called 2μm plasmid present in
Eukaryotic cells
6kb in size, high copy number 70-200
Replication depend on
1. plasmid origin
2.enzymes by host cell
3. proteins encoded by REP1 AND REP2
FLP gene –inversion of set of sequences within the plasmid
Carry genes conferring resistance to inhibitors such as methotrexate,copper
Ti PLASMID OF Agrobacterium tumefaciens
-soil microorganism-causes crown gall disease
-crown gall occurs as follows
1.Wound on a stem
2. A.tumefaciens invade the plant
3. infection- cancerous proliferation-at region of crown
-Lipopolysaccharides(polygalactouronic) make phenolic compounds to induce vir gene-vir gene produce enzyme that produce ssDNA with nick on same strand-leads to opine synthesis(for proliferation of bacteria)-auxin and cytokinin- disorganised proliferation of cells-leads to crown gall
- Ability to cause crown gall is ti plasmids-tumour inducing plasmid within bacterial cell
-large plasmid, greater than 200kb, carries numerous genes invloved in infective process.
-after infection part of molecule integrated to plant chromosomal DNA-segment T-DNA-15-30kb in size
-maintained as a stable form in plant cell-passed on to daughter cells
-phenolic compounds released are acetosyringone and hydroxysyringone
-vir genes-35 kb-contains site for opine synthesis and opine catabolism
-2 main strategies involved in inserting new DNA molecule into plasmid
1. BINARY VECTOR STRATEGY 2.CO INTEGRATIVE STRATEGY
Because of the nearly unlimited upscaling possibility, transgenic plants represent a very promising expression system for recombinant antibodies.https://www.creativebiolabs.net/magic-plant-cell-expression-service.htm
This document summarizes research on a single-chain peptide analog of the Holliday junction-binding homodimer (wrwycr)2. The peptide wrwyrggrywrw was characterized and found to effectively bind Holliday junction DNA and inhibit DNA repair enzymes like the parental peptide, with equal or greater antibacterial potency against gram-positive and gram-negative bacteria. Treatment with wrwyrggrywrw was shown to cause DNA damage in bacteria and disrupt the bacterial cell membrane. The peptide had low toxicity toward eukaryotic cell types at antibacterial concentrations.
PCUBE--Protein Production Platform for mAb generation. Part Icarlociatto
1. HEK293E cells and an episomal vector were used to transiently express monoclonal antibodies in suspension culture. Transfection with polyethylenimine resulted in high and sustained protein expression over 8 days.
2. For larger scale production, adherent 293E cells were grown in a disposable packed-bed bioreactor containing 12,000 cm2 of growth surface in 500 mL volume. Protein expression lasted over a month with repeated batch culture.
3. A monoclonal antibody was expressed using this system, purified by protein A chromatography, and confirmed to be the correct protein by mass spectrometry. Immunized mouse sera recognized the recombinant protein.
Guide to Molecular Cloning - Download the GuideQIAGEN
Molecular cloning can be sometimes tricky with significant challenges involved. Overcome the challenges with the essential knowledge and tips for successful cloning.
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxwalterHu5
In some case, your chronic prostatitis may be related to over-masturbation. Generally, natural medicine Diuretic and Anti-inflammatory Pill can help mee get a cure.
More Related Content
Similar to GeneMedi-Adenovirus production protocol-packaging concentration and purification
A new system called the "admid system" has been developed for efficiently generating recombinant adenoviruses in E. coli. The system uses Tn7-mediated transposition to insert expression cassettes into an adenoviral genome plasmid (admid) maintained in E. coli. Transfer vectors containing the expression cassette flanked by Tn7 elements transpose the cassette into the E1 region of the admid. Recombinant admids produce infectious adenovirus after transfection into producer cells. The system generates pure, clonal adenovirus stocks without multiple rounds of purification. It allows rapid, high-throughput production of recombinant adenoviruses for gene therapy and other applications.
1. The document provides guidelines for safely conducting experiments with lentiviruses, which should be done in a biosafety level 2 facility and while wearing proper protective equipment.
2. Lentiviruses should be stored at -80°C for long-term storage and diluted in ice water or medium kept at 4°C.
3. Recombinant lentiviruses are produced by co-transfecting lentiviral, envelope, and packaging plasmids into 293T cells, collecting the supernatant, and purifying and titrating the virus.
Cloning vectors are small DNA molecules that are used to artificially carry foreign genetic material into host cells. They contain features like an origin of replication, antibiotic resistance genes, and restriction enzyme sites. The document discusses different types of cloning vectors used for plant gene cloning, including plasmids, Ti/Ri plasmids from Agrobacterium, and plant viruses. Agrobacterium-mediated transformation uses disarmed Ti plasmids from Agrobacterium tumefaciens and involves co-cultivation of plant explants with Agrobacterium, selection of transformed cells, and regeneration of whole plants. Binary vector systems are now commonly used, involving transfer of a binary plasmid without integration into the Ti plasmid
DNA cloning techniques allow for the reproduction of DNA fragments. There are two main approaches: cell-based cloning using living cells and in vitro cloning using PCR. The cloning process involves cutting out the gene of interest and a host plasmid with the same restriction enzyme, ligating the gene into the plasmid, transforming bacteria with the new plasmid, and selecting for transformed colonies. Common cloning vectors include plasmids, bacteriophages, cosmids, YACs, and retroviral vectors which allow incorporation of foreign DNA into host genomes. PCR cloning strategies like TA cloning take advantage of Taq polymerase adding extra adenines to PCR products, allowing ligation into vectors with thymidine overhangs.
PRODUCTION OF SEROTYPE 6-DERIVED RECOMBINANT ADENO-ASSOCIATED VIRUS IN SERUM-...Dr. Érica Schulze
This document describes research into producing recombinant adeno-associated virus (rAAV) using serum-free suspension cultures of HEK 293 cells. The researchers investigated the effects of different DNA, polyethyleneimine (PEI) transfection reagent, and cell concentrations on rAAV yields. They found that transfecting at a cell concentration of 3x10^6 cells/mL resulted in a 2.5-3.5 fold increase in infectious virus particles (IVP) and genomic particles (Vg) compared to 1x10^6 cells/mL. When testing different PEI:DNA ratios, IVP ranged from 1.19x10^8 to 1.03x10^9 IVP/
This document summarizes a single-use platform for purifying adenovirus at scale. The platform uses disposable filters, cassettes, and membrane adsorbers to purify adenovirus from cell culture harvest in one day. Key steps include clarification with a depth filter, concentration/diafiltration with ultrafiltration cassettes, primary purification on a Q membrane adsorber, polishing with an STIC membrane to remove DNA, and final concentration/buffer exchange. The platform achieved 55% overall yield while meeting targets for host cell protein, DNA, and endonuclease concentration in the final product. It provides a standardized process that can be easily scaled up and reduces development time for new viral vaccine products
A comprehensive study of shuttle vector & binary vector and its rules of in ...PRABAL SINGH
Vector: A vector is a DNA molecule that has the ability to replicate autonomously in an appropriate host cell and into which the DNA fragment to be cloned is integrated for cloning
Recombinant DNA technology involves joining DNA fragments from different sources to create a new DNA fragment. This involves selecting the target DNA, a cloning vector to carry the inserted DNA, DNA ligases to join the pieces, restriction enzymes to cut the DNA, and a host cell to replicate the new DNA. Common vectors include bacterial plasmids and phages that can carry inserted DNA fragments of varying sizes. The process involves cutting, joining, and replicating the DNA within the host cell. Applications include gene therapy, transgenic plants and animals, and industrial production of proteins and chemicals. Recent advances allow modifying proteins through site-directed mutagenesis.
This document discusses various gene transfer methods in animals, including viral and non-viral approaches. Viral methods include retroviruses, adenoviruses, adeno-associated viruses, baculoviruses, which can integrate the transferred gene into the host cell's genome. Non-viral methods discussed are transfection techniques like calcium phosphate precipitation, DEAE-dextran, lipids, microinjection, gene guns, ultrasound, and electroporation. These physical methods deposit naked DNA directly into cells without viral vectors. The document provides detailed protocols for many of these gene transfer techniques.
This document discusses different types of cloning vectors. It describes that vectors are used to carry foreign DNA into host cells. There are two main types of transformation vectors - cloning vectors which are used to increase copies of cloned DNA fragments, and expression vectors which are used to express foreign genes as proteins. Some examples of commonly used cloning vectors include pBR322 and pUC18/19, while examples of expression vectors include pET28 and pRSET vectors. The document then discusses various properties desirable in vectors such as an origin of replication, antibiotic resistance genes, and regulatory elements. It describes different types of vectors including plasmid vectors, bacteriophage vectors, cosmids, BACs/YACs, and mini chromosomes.
jove-protocol-51306-using-rna-interference-to-investigate-innate-immune-respo...Brandon S Guthrie
This document summarizes a protocol for using RNA interference (RNAi) to investigate the innate immune response in mouse macrophages. The protocol describes optimizing transfection of two mouse macrophage cell lines, RAW264.7 and J774A.1, using a 96-well nucleofection system. It then details monitoring the effects of RNAi-mediated gene knockdown on the innate immune response after stimulating the macrophages with lipopolysaccharide (LPS). As an example, it discusses using RNAi to inhibit Toll-like receptor family members, which sense LPS and regulate innate immunity.
This document summarizes a seminar presentation on the production of DNA vaccines. It begins by discussing the importance of vaccines in addressing infectious diseases and problems with traditional vaccines. It then covers topics like the advantages of DNA vaccines over recombinant protein vaccines, designing plasmid DNA constructs for vaccines, antigen expression systems, successful DNA vaccines to date, delivery methods like needle-free injection and microspheres, and the use of adjuvants to enhance vaccine activity.
The document discusses various methods of transfection in animals. Transfection is the process of introducing nucleic acids into eukaryotic cells. It describes viral transfection using bacteria like Agrobacterium tumefaciens and viruses. Non-viral methods include chemical transfection using calcium phosphate, liposomes, polyamines. Mechanical transfection employs microinjection or particle bombardment. Common chemical methods are calcium phosphate precipitation, polyplexes, and liposomes/lipoplexes. Viruses used are retroviruses, adenoviruses, adeno-associated viruses. Bacterial and viral vectors allow for integration into the host genome while chemical and mechanical are often transient.
This study evaluated the effectiveness of using a lentivirus delivery system to introduce CRISPR/Cas9 genome editing in a salmonid fish cell line. The researchers optimized transfection conditions and achieved up to 60% editing efficiency at the desired RIG-I and EGFP loci. While lentivirus integration led to high editing rates, it can also result in off-target effects. The study demonstrated the potential of CRISPR/Cas9 for modeling disease resistance in fish, though more work is still needed to minimize off-target mutations.
CLONING VECTORS FOR YEAST AND Agrobacterium tumefaciens.pptxsandhyagokulnathan
A cloning vector is a DNA molecule that is used to carry a foreign DNA into the host cell. It has the ability to self replicate and integrate into the host cell.Saccharomyces cerevisiae. Development of plasmid is most commonly found in strains of S. cerevisiae its called 2μm plasmid present in
Eukaryotic cells
6kb in size, high copy number 70-200
Replication depend on
1. plasmid origin
2.enzymes by host cell
3. proteins encoded by REP1 AND REP2
FLP gene –inversion of set of sequences within the plasmid
Carry genes conferring resistance to inhibitors such as methotrexate,copper
Ti PLASMID OF Agrobacterium tumefaciens
-soil microorganism-causes crown gall disease
-crown gall occurs as follows
1.Wound on a stem
2. A.tumefaciens invade the plant
3. infection- cancerous proliferation-at region of crown
-Lipopolysaccharides(polygalactouronic) make phenolic compounds to induce vir gene-vir gene produce enzyme that produce ssDNA with nick on same strand-leads to opine synthesis(for proliferation of bacteria)-auxin and cytokinin- disorganised proliferation of cells-leads to crown gall
- Ability to cause crown gall is ti plasmids-tumour inducing plasmid within bacterial cell
-large plasmid, greater than 200kb, carries numerous genes invloved in infective process.
-after infection part of molecule integrated to plant chromosomal DNA-segment T-DNA-15-30kb in size
-maintained as a stable form in plant cell-passed on to daughter cells
-phenolic compounds released are acetosyringone and hydroxysyringone
-vir genes-35 kb-contains site for opine synthesis and opine catabolism
-2 main strategies involved in inserting new DNA molecule into plasmid
1. BINARY VECTOR STRATEGY 2.CO INTEGRATIVE STRATEGY
Because of the nearly unlimited upscaling possibility, transgenic plants represent a very promising expression system for recombinant antibodies.https://www.creativebiolabs.net/magic-plant-cell-expression-service.htm
This document summarizes research on a single-chain peptide analog of the Holliday junction-binding homodimer (wrwycr)2. The peptide wrwyrggrywrw was characterized and found to effectively bind Holliday junction DNA and inhibit DNA repair enzymes like the parental peptide, with equal or greater antibacterial potency against gram-positive and gram-negative bacteria. Treatment with wrwyrggrywrw was shown to cause DNA damage in bacteria and disrupt the bacterial cell membrane. The peptide had low toxicity toward eukaryotic cell types at antibacterial concentrations.
PCUBE--Protein Production Platform for mAb generation. Part Icarlociatto
1. HEK293E cells and an episomal vector were used to transiently express monoclonal antibodies in suspension culture. Transfection with polyethylenimine resulted in high and sustained protein expression over 8 days.
2. For larger scale production, adherent 293E cells were grown in a disposable packed-bed bioreactor containing 12,000 cm2 of growth surface in 500 mL volume. Protein expression lasted over a month with repeated batch culture.
3. A monoclonal antibody was expressed using this system, purified by protein A chromatography, and confirmed to be the correct protein by mass spectrometry. Immunized mouse sera recognized the recombinant protein.
Guide to Molecular Cloning - Download the GuideQIAGEN
Molecular cloning can be sometimes tricky with significant challenges involved. Overcome the challenges with the essential knowledge and tips for successful cloning.
Similar to GeneMedi-Adenovirus production protocol-packaging concentration and purification (20)
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxwalterHu5
In some case, your chronic prostatitis may be related to over-masturbation. Generally, natural medicine Diuretic and Anti-inflammatory Pill can help mee get a cure.
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
Osteoporosis - Definition , Evaluation and Management .pdfJim Jacob Roy
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
- Video recording of this lecture in English language: https://youtu.be/Pt1nA32sdHQ
- Video recording of this lecture in Arabic language: https://youtu.be/uFdc9F0rlP0
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
5-hydroxytryptamine or 5-HT or Serotonin is a neurotransmitter that serves a range of roles in the human body. It is sometimes referred to as the happy chemical since it promotes overall well-being and happiness.
It is mostly found in the brain, intestines, and blood platelets.
5-HT is utilised to transport messages between nerve cells, is known to be involved in smooth muscle contraction, and adds to overall well-being and pleasure, among other benefits. 5-HT regulates the body's sleep-wake cycles and internal clock by acting as a precursor to melatonin.
It is hypothesised to regulate hunger, emotions, motor, cognitive, and autonomic processes.
Adhd Medication Shortage Uk - trinexpharmacy.comreignlana06
The UK is currently facing a Adhd Medication Shortage Uk, which has left many patients and their families grappling with uncertainty and frustration. ADHD, or Attention Deficit Hyperactivity Disorder, is a chronic condition that requires consistent medication to manage effectively. This shortage has highlighted the critical role these medications play in the daily lives of those affected by ADHD. Contact : +1 (747) 209 – 3649 E-mail : sales@trinexpharmacy.com
These lecture slides, by Dr Sidra Arshad, offer a simplified look into the mechanisms involved in the regulation of respiration:
Learning objectives:
1. Describe the organisation of respiratory center
2. Describe the nervous control of inspiration and respiratory rhythm
3. Describe the functions of the dorsal and respiratory groups of neurons
4. Describe the influences of the Pneumotaxic and Apneustic centers
5. Explain the role of Hering-Breur inflation reflex in regulation of inspiration
6. Explain the role of central chemoreceptors in regulation of respiration
7. Explain the role of peripheral chemoreceptors in regulation of respiration
8. Explain the regulation of respiration during exercise
9. Integrate the respiratory regulatory mechanisms
10. Describe the Cheyne-Stokes breathing
Study Resources:
1. Chapter 42, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 36, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 13, Human Physiology by Lauralee Sherwood, 9th edition
2. 2
adenovirus (AdV)
Introduction of Recombinant adenovirus (AdV)
Recombinant adenovirus (rAdV) is a replication-defective adenoviral vector, which is widely used for a variety of
purposes including gene transfer and engineering, vaccination and gene therapy [1,2]. There are several advantages
of using adenovirus as a gene transfer mediator. Firstly, it can deliver as large as 8 kilo-base (kb) gene sequences
into cells and tissues without insertion of exogenous fragment in the genome. Secondly, almost all the dividing and
non-dividing cells, primary cells and organ tissues can be transduced by recombinant adenovirus. Moreover,
recombinant adenovirus is easy to operate and expand into large-scale, and the efficiency can reach up to 100%.
Thus, recombinant adenovirus plays an important role in gene engineering research and potential therapeutic
treatment of diseases.
The most commonly used adenovirus is serotype 5 (Ad5) of Homo Sapiens consisting of a double-stranded linear
DNA molecule at about 36 kb in size1. The cytoplasmic membrane receptors and fibers facilitate endocytosis of
adenovirus into cell cytoplasm, where adenovirus particles further migrate into cell nucleus for self-replication using
replication machinery of the host [3]. Once replicated, the adenovirus genome is assembled into its protein shell and
released from cells, causing cell lysis [3].
Nowadays, several packaging systems of recombinant adenovirus are developed, in which AdEasy1 and AdMAX2
are the two most popular ones, sharing a common strategy that target gene sequence is cloned into an adenovirus
expression vector (adenovirus shuttle vector), then recombined into a viral backbone vector. Early viral transcription
units, E1 and E3, are defected in both of these two systems, while E3 gene is not necessary for adenovirus
replication1. Thus, packaging of recombinant adenovirus is usually conducted in cell lines expressing E1 gene, such
as HEK-293, HEK-293A, etc. [2].
In comparison with AdEasy, AdMAX system is relatively easy to handle and can achieve higher adenovirus titer
during adenovirus production. This recombinant adenovirus protocol is developed according to AdMAX system,
using a two-vector system composed of adenovirus expression plasmids (adenovirus shuttle vectors) with different
promoters and tags, and an adenovirus genome backbone plasmid with E1 region deletion.
Protocol Overview
A schematic overview of recombinant adenovirus (AdV) production is shown in Figure 1. The first step is to clone
the gene of interest (GOI) into an appropriate plasmid vector. For most applications, the cDNA of interest is cloned
into one of the recombinant adenovirus expression vectors. The inverted terminal repeat (ITR) sequences present in
these vectors provide all of the cis-acting elements necessary for recombinant adenovirus replication and packaging.
The recombinant expression plasmid is co-transfected into the 293A cells (an E1-complementing cell line) with
adenovirus genome backbone plasmid, which together supply all of the trans-acting factors required for adenovirus
replication and packaging.
GeneMedi
3. 3
Small plaques can be visualized under microscope 10 to 21 days post-transfection. Pick three to six individual
plaques and compare their adenovirus titer, then select the one with highest titer to proceeded subsequent
amplification, concentration and purification experiments.
Figure 1. Adenovirus packaging experiment flow chart.
Experimental Materials
GeneMedi's adenovirus Vector System
GeneMedi's adenovirus Vector System, also named the adenovirus expression system or adenovirus packaging
plasmid system, is a powerful tool for in-vitro & in-vivo gene delivery, shRNA mediated RNA interference (RNAi)
and gene editing. You can easily recombine produce a recombinant adenovirus (r-AdV) particle in HEK293 or
HEK293A cell line in high titer using GeneMedi's adenovirus Vector System.
The Genemedi adenovirus vector system including 2 types of adenovirus packaging plasmids: the adenovirus
expression plasmids (adenovirus shuttle vectors) with different promoters and tags, and an adenovirus genome
backbone plasmid with E1 region deletion.
GeneMedi
4. 4
GeneMedi has developed a variety of adenovirus expression vectors with different expression cassettes, containing
kinds of verified promoters and reporters including GFP, zsgreen, RFP, mcherry and luciferase. The GeneMedi's
adenovirus expression vectors have been proved very suitable for unique gene overexpression or shRNA-mediated
knock-down (also called RNAi (RNA interference ). You can also achieve gene knock-out(KO) or gene editing
using our Crispr-cas9-gRNA adenovirus expression vector.
Visit https://www.genemedi.net/i/adenovirus-vector-system for more information about GeneMedi’s adenovirus
vector system and multiple adenovirus expression vectors (adenovirus shuttle vectors).
Bacterium Strain
E. coli strain DH5ɑ is used for amplification of adenovirus expression plasmids (adenovirus shuttle vectors) and
adenovirus backbone vector.
Packaging Cell Line
293A is the adenovirus packaging cell line that can facilitate initial production, amplification and titer determination
of recombinant adenovirus. It is an adherent, epithelial-like cell line expressing E1 proteins required for adenovirus
replication, and grows into a monolayer when confluent. Originated from the 293 cell line and established for plaque
assays, this cell line was identified to be an easy-to-handle transfection host.
The complete growth medium of 293A is Dulbecco's Modified Eagle Medium (DMEM) supplemented with 10%
Fetal Bovine Serum (FBS) and 1% Penicillin-Streptomycin (Pen-Strep). For a continuous culture, cells should not
exceed 70% confluence to maintain proper characteristics. Usually, starting from cell passage number one, optimal
results can be obtained within 30 passages. Once reached, it is best to start a new culture from another frozen stock
in case of any unexpected mutations and unhealthy growth. Therefore, banking your own 293A frozen stocks is very
important to ensure experimental integrity and continuity. Freezing cells at the logarithmic phase will improve post-
thaw viability.
Notices:
If the cell line is contaminated by mycoplasma, to reach a better-cultured cell state, we recommend the use of
Genemedi anti-mycoplasma reagent CurePlasmaTM
.
Packaging Cell Line
Gene of interest
LB broth
Agar and Agarose
Kanamycin
Ampicillin
70 and 100% ethanol
Sterile PBS
Cesium chloride (CsCl)
Chlorine bleach
GeneMedi
5. 5
DNA gel apparatus and power supplies
Class II Biosafety Cabinet
37℃ orbital shaker
37℃ bacteria incubator
37℃, 5% CO2 incubator
15- and 50-ml conical tubes
25- and 75-cm2
tissue culture flasks
Cell scrapers
Dry-ice/methanol bath
Liquid nitrogen tank
Ultracentrifuge (Beckman) or equivalent with SW28 rotor
Low-speed swinging-bucket centrifuge
Microcentrifuge
Centrifuge tube (thick-wall polycarbonate tube with cap)
Ring stand and clamp, 3-ml syringes and 18-G needles
Packaging and Concentration of Adenovirus
Vector Construction of Adenovirus
Before recombinant adenovirus packaging, the gene of interest should be constructed into recombinant adenovirus
expression vector. Genemedi also provides various Adenovirus vectors with alternative promoters and fluorescent
labels (Table 1). What’s more, Genemedi has plenty of premade Adenovirus vector goods carrying some genetic
tools in stock, such as adenovirus-LC3 autophagy flux detection biosensors, etc.
Visit https://www.genemedi.net/i/virus-plasmid to find more about Genemedi’s ORF/CDNA premade adenovirus
expression vectors
Note:
In order to construct vectors quickly and efficiently, it is strongly recommended to use Genemedi- ClonEasyTM
One
Step Cloning Kit(Cat. GM-GC-01/02/03).
Visit https://www.genemedi.net/i/cloneasy-one-step-cloning-kit to find more about Genemedi - ClonEasyTM
One
Step Cloning Kit
Transfection of adenovirus Plasmids into 293A Packaging Cells
a. 293A cell culture should be prepared at least a day ahead to reach a confluence of 50%-70% monolayer
morphology prior to transfection.
b. On the day of transfection, DMEM needs to be pre-warmed at 37℃ water bath and LipoGeneTM
transfection
reagent should be equilibrated to room temperature and tapped to mix before use.
c. To prepare viral plasmids for each reaction using a 60-mm dish:
GeneMedi
6. 6
Table 1. Adenovirus vector system plasmids and transfection reagent required for transfection.
Component Amount
pAd expression vector with GOI 2 μg
adenovirus genome backbone
plasmid
4 g
LipoGeneTM
30 l
d. Mix plasmids with transfection reagent in DMEM and add drop-wise to pre-seeded 293A cells. Incubate at 37℃,
5% CO2 and refresh with complete culture medium in 6 hours.
Note:
1. A detailed protocol of the transfection reagent can be referred to Genemedi LipoGeneTM
Transfection Reagent
User Manual.
Click here to find more about Genemedi - LipoGeneTM
Transfection Reagent
2. Cells should be in a healthy growth state for use prior to transfection.
Plaque Formation and Cell Collection
Plaque is an area of monolayer cells that display a cytopathic effect when infected by adenoviruses, usually observed
as round, darker cells or white spots with microscope or naked eyes (Figure 1). It is important to observe viral
plaques before collecting the transfected cells.
a. To minimize the spreading of adenovirus for a better condition of adenovirus plaque formation, low-melting-
point agarose is suggested to be added in regular medium with a final concentration of 1.25%.
b. Small plaques can be visualized under microscope 10 to 21 days post-transfection. If the engineering sequence
in the adenovirus expression plasmid carries fluorescent tags (GFP or RFP), the transfection efficiency can be
estimated with fluorescence microscopy before production of plaques.
c. Pick an isolated viral plaque together with surrounding agarose, and transfer into 1 ml fresh medium and
incubate overnight. In general, three to six plaques should be picked to compare their adenovirus titer, then the
one with highest titer will be proceeded into subsequent experiments.
Figure 1. Identification of a plaque.
GeneMedi
7. 7
Note:
A stock solution of high-purity low-melting-point agarose can be prepared in sterile PBS to a final concentration of
5%. Before use, melt the stock completely in boiling water bath, and gradually cool down to 45 ℃ at room
temperature. Dilute the agarose stock solution using pre-warmed 37 ℃ complete growth media to a final
concentration of 1.25%. Immediately and gently add the well-mixed solution to cells with culturing medium removed
ahead, and rotate to evenly covering the plaque cells. For a 6-well plate, add 3 ml agarose/medium per well.
It is important to observe viral plaques before collecting the transfected cells. To minimize the spreading of
adenovirus for a better condition of adenovirus plaque formation, low-melting-point agarose is suggested to be
added in regular medium, and small plaques can be visualized under microscope 10 to 21 days post-transfection. If
the engineering sequence in the adenovirus expression plasmids (adenovirus shuttle vectors) carries fluorescent
tags (GFP or RFP), the transfection efficiency can be estimated with fluorescence microscopy before production of
plaques.
adenovirus Amplification
a. On the next day, add adenovirus-containing supernatant into fresh, pre-seeded 293A cells to amplify adenovirus.
b. Collect cells and supernatant when observing formation of plaques, and proceed into a freeze-thaw cycle 3 times
before collecting all adenoviruses.
c. The collected adenovirus is recognized as passage 1 (P1 adenovirus). Then, infect fresh 293A cells with P1
adenovirus.
d. Perform infection-collection cycle for three times till P4 adenovirus is obtained, and expand adenovirus
production into large-scale through P4 adenovirus infection. When formation of plaques is observed,
adenoviruses are collected for purification and concentration.
Note:
1. Use a cell scraper instead of trypsinization to detach cells. Collected cells should be centrifuged at 500 g, 4℃
for 10 min. Discard the most supernatant and leave 2ml to resuspend the cell pellet, transfer to a container at
lower than -80℃ (using dry ice or liquid nitrogen) for freezing and thawing.
2. Immediately remove from the 37 ℃ bath when the adenovirus suspension melts completely in case of any
decrease of the adenovirus titer. Shake the completely melted suspension heavily for 30 seconds. Usually, two to
four rounds of freeze-thaw cycle can improve the yield of adenoviruses with high titer.
3. After freeze-thaw cycles, adenovirus lysate can be centrifuged at 500 g, 4℃ for 10 min to remove cell debris,
and stored at -80℃ for later use.
adenovirus Purification
The purification process of recombinant adenovirus is composed of three steps: PEG8000 condensation, CsCl
density gradient centrifugation and dialysis. The detailed operation process is as following:
GeneMedi
8. 8
a. Thaw: Take the adenovirus out from -80 centigrade one day in advance, and melt in water bath at room
temperature. Centrifuge at 7000 g, 4℃ for 10 min and collect supernatant.
b. PEG8000 condensation: Add 50 ml PEG8000 solution (20% PEG8000 in ultra-pure water with 2.5 M NaCl) per
100ml supernatant, placing on ice for 1 hour to pull-down adenoviruses (Time for incubation on ice can be
relatively extended). Centrifuge the mixture for 20 min at 7000 g, 4℃, discard the supernatant and resuspend
adenovirus pellet in 10 ml CsCl solution at density of 1.10g/ml (solvent of CsCl is 20mM Tris-HCl, pH8.0,
please see the following CsCl solution preparation method in table 2). The adenovirus-containing CsCl solution
should be pink (Figure 2).
Table 2. CsCl solution preparation.
Density at 20℃ (g/ml) Concentration (ml/ml) Amount of CsCl (g) Final Volume (ml)
1.40 548.3 5.483 10
1.30 402.4 4.024 10
1.20 143.8 1.438 10
c. CsCl density gradient centrifugation: Place 2 ml of 1.40 g/ml CsCl solution on the bottom of a centrifuge tube,
next add 3 ml of 1.30 g/ml CsCl solution slowly on top of the first layer, then add 5 ml adenovirus suspension.
Centrifuge with Beckman SW28 rotor at 26,000 rpm, 4℃ for 2 hours.
Figure 2. CsCl density gradient centrifugation process.
Left panel: CsCl gradient before ultracentrifugation.
Right panel: CsCl gradient after ultracentrifugation.
d. adenovirus collection: Collect adenovirus band between 1.30g/ml and 1.40g/ml layers with a syringe, transfer
into dialysis bag.
Note:
The dialysis bag should be boiled in 10 mM EDTA-Na2 for 10 min, cool down to room temperature before use.
e. Dialysis: Put the dialysis bag containing adenovirus in dialysis buffer (50 g sucrose, 10 ml 1 M Tris-HCl, PH 8.0,
2 ml 1 M MgCl2, top up to 1 L by distilled water), and stir at 4℃ overnight. Replace with fresh buffer once
during dialysis.
f. Formulation: Collect adenovirus from the bag, adjust volume to 500 µl with PBS, and determine the titer.
Purified recombinant adenovirus should be kept in 4℃ for no more than a week or in -80℃ for long time storage.
GeneMedi
9. 9
Titration of Purified recombinant adenovirus
The titer determination method of recombinant adenovirus is plaque assay. Plaque-forming unit (PFU) is the number
of plaques induced by certain volume of adenoviruses, representing the concentration of active viral particles.
Plaque assay of recombinant adenovirus:
a. Plate 293A cells in 60-mm dishes at least one day in advance.
b. When cell confluence reaches approx. 100%, add diluted adenovirus at different concentrations and incubated at
37℃.
c. 4 to 8 hours post infection, cover cells with 8 ml low-melting-point agarose solution (10% FBS, 1.25% agarose).
d. Calculate the titer of recombinant adenovirus by counting number of plaques in 9-11 days of culturing.
Note:
Titer of recombinant adenovirus can also be determined by observing fluorescence when applicable, or through the
method of Western blotting (WB), immunofluorescence (IF) and immunohistochemistry (IHC) detection on
expression level of target genes.
Transduction of Target Cells
For the reason that MOI varies in different cell lines, preliminary experiment is necessary to ensure a proper MOI of
target cells before conducting formal experiments.
Note:
MOI: multiplicity of infection, is the number of viral particles to infect one cell. An optimization test of MOI is
strongly recommended as the real MOI to certain cells may be affected by the operations and methods of dealing
with adenoviruses in different labs.
Cell Preparation
Plate robust target cells into 24-well plates at a density of 1 x 105
/ml.
Note:
The number of planted cells depends on the growth rate of the relevant cell line. 50% to 70% confluence should be
reached on the following day.
MOI Test of recombinant adenovirus
Prepare the adenovirus in 10-fold dilution gradient, and ensure the MOI is within a range of 3 to 1000.
GeneMedi
10. 10
Day 0: Plate target cells in good condition at a density of 1 x 105
/ml into 96-well plates, 100 µl per well. Incubate at
37℃ overnight.
Day 1: Prepare adenovirus in a six-MOI gradient, and dilute proper amount of adenovirus suspension in complete
culture medium of target cell to a final volume of 100 µl (setting MOI=3, 10, 30, 100, 300, 1000). Add diluted
adenoviruses to pre-seeded cells and incubate for 4 to 8 hours at 37 ℃ , then refresh the medium to remove
adenoviruses.
Day 3: Detect fluorescence with a microscope. Calculate MOI based on the ratio of fluorescent cells.
Note:
If the adenovirus is not fluorescence-labeled, MOI can be determined by qPCR, WB, IF, IHC, etc.
Transduction
Prepare the adenovirus in 10-fold dilution gradient, and ensure the MOI is within a range of 3 to 1000.
a. For adherent cells:
Recombinant adenovirus containing target gene and the same amount of control adenovirus should be added
separately into two groups of cells and mixed well. The amounts of adenoviruses to be used are based on size of
container described in the following table. For MOI test in most cell types, a gradient of 3, 10, 30, 100, 300 to1000
at three replicates would be sufficient enough. Refresh medium in 4 to 8 hours. Protein of interests can be detected
within 48-72 hours with fluorescence microscopy, WB, etc.
Table 3. adenoviruses amounts in different container size.
Size of Container Surface Area (cm2
) Volume of Medium Volume of
adenoviruses
96-well 0.3 100 µl 0.1-0.5 µl
24-well 2 500 µl 1-3 µl
12-well 4 1 ml 2-5 µl
6-well 10 2 ml 5-20 µl
For example: If the tier of recombinant adenovirus is 5 × 1011
PFU/ml, dilute to 5 × 1010
PFU/ml (10-fold) with
complete growth medium of target cells. When there are 1 × 105
cells in one well, and the MOI is 1,000, required
volume of diluted adenovirus (5 × 1010
PFU/ml) should be (cell number) × (MOI) ÷ (PFU/ml of recombinant
adenovirus) = 1 × 105
× 1,000 / 5 × 1010
(ml) = 2 µl. Thus, 2 ul of diluted adenovirus should be added into this well.
Note:
The waste should be disposed following procedures described in Biosafety Requirements Section.
b. For suspension cells:
Spin infection is a sufficient way to transduce suspension or semi-suspension cells. In brief, seal the cell culture plate
by parafilm after adding adenoviruses, spin in a low-speed swinging-bucket centrifuge at 200g for 1 hour at 37℃,
GeneMedi
11. 11
and culture cells at 37℃ overnight. Medium should be refreshed the next day.
If the condition is not allowed for spin infection, a centrifuge tube can be used instead by transferring cells into a
tube and centrifuge at low-speed. Discard most of the supernatant after centrifugation, add adenoviruses, and
incubate at room temperature for 15-30 min. Then transfer the cell-adenovirus mixture into a proper container, and
culture at 37℃ overnight. Medium should be replaced the next day.
Determine Transduction Efficiency
48 to 72 hours post-transduction, fluorescent proteins can be observed when applicable, and the alteration of target
gene can be analyzed at mRNA-level by qPCR or at protein-level by Western blot (WB).
Safe Use of adenovirus (AdV)
1. Adenovirus related experiments should be conducted in biosafety level 2 facilities (BL-2 level).
2. Please equip with lab coat, mask, gloves completely, and try your best to avoid exposing hand and arm.
3. Be careful of splashing adenovirus suspension. If biosafety cabinet is contaminated with adenovirus during
operation, scrub the table-board with solution comprising 70% alcohol and 1% SDS immediately. All tips, tubes,
culture plates, medium contacting adenovirus must be soaked in chlorine-containing disinfectant before disposal.
4. If centrifuging is required, a centrifuge tube should be tightly sealed. Seal the tube with parafilm before
centrifuging if condition allowed.
5. Adenovirus related animal experiments should also be conducted in BL-2 level.
6. Adenovirus associated waste materials need to be specially collected and autoclaved before disposal.
7. Wash hands with sanitizer after experiment.
Storage and Dilution of Adenovirus
Storage of Adenovirus
Adenovirus can be stored at 4°C for a short time (less than a week) before using after reception. Since adenoviruses
are sensitive to freeze-thawing and the titer drops with repeated freeze-thawing, aliquot viral stock should be stored
at -80 ° C freezer immediately upon arrival for long-term usage. While adenovirus titer redetection is suggested
before using if the adenoviruses have been stored for more than 12 months.
Note: 1. Repeated freeze-thaw cycles must be avoided in case of a downside effect on adenovirus titer (for each
freeze-thaw cycle, there would be a 10%-50% decrease). Genemedi will provide recombinant adenovirus products in
small aliquots (200 µl/tube) that can be directly stored in -80 centigrade for multiple usage.
2. For adenoviruses stored for more than 6 months, it is suggestive to re-analyze adenovirus titer before use.
GeneMedi
12. 12
Dilution of Adenovirus
To properly thaw recombinant adenovirus frozen aliquots, transfer adenoviruses from -80℃ freezer to an ice-water
bath till completely melted. When melted, add proper amount of sterile PBS or serum-free culture medium, and keep
in 4℃ for no more than a week.
Precautions
· Avoid Adenovirus exposure to environmental extremes (pH, chelating agents like EDTA, temperature, organic
solvents, protein denaturants, strong detergents, etc.)
· Avoid introducing air into the Adenovirus samples during vortexing, blowing bubbles or similar operations,
which may result in protein denaturation.
· Avoid repeated freezing and thawing.
· Avoid exposing to “regular” plastics (especially polystyrene or hydrophobic plastics) for prolonged periods in
liquid phase. Most adenoviruses are very sticky and loss can occur if exposed to regular plastics, including tubes,
cell culture plates, pipette tips, if not frozen. It is best to store Adenovirus in siliconized or low protein binding tubes.
Pluronic F-68 used at 0.01%-0.1% in the formulation buffer will minimize sticking if regular plastics are used.
· Avoid diluting Adenovirus into low salt solution. Some adenoviruses aggregate in low salt solution, which will
be non-infectious.
References
1. Luo J. et al. A protocol for rapid generation of recombinant adenoviruses using AdEasy system. Nat. Protocols. 2 (5), 1236-1247 (2007).
2. He T. C. et al. A simplified system for generating recombinant adenoviruses. PNAS. 95, 2509-2514 (1998).
3. Meier O. & Greber U. F. adenovirus endocytosis. J. Gene Med. 6 (Suppl 1), S152-S163 (2004).
Related products
1. AAV packaging system
More details please visit: https://www.genemedi.net/i/aav-vector-system
GeneMedi